News & Updates

Serum DHEA, testosterone levels inversely linked to CAC in older men

In older men, serum levels of dehydroepiandrosterone (DHEA) and testosterone correlate inversely with coronary artery calcification (CAC), partially independently from each other, a study has shown.

Product Highlight - Ivcort

Hydrocortisone Na succinate Powd for inj 100 mg

Even seemingly healthy teens with high BMI at risk of early CKD

High body mass index (BMI) in late adolescence appears to be a risk factor for chronic kidney disease (CKD) in young adulthood, even for seemingly healthy individuals with a BMI that falls within the normal range but is closer to the upper limit, as reported in a study.

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

Etelcalcetide proves beneficial in the real-world treatment of secondary hyperparathyroidism (SHPT) in multiethnic Asian haemodialysis patients, with the added advantage of reducing pill burden, as shown in a study from Singapore.

Supplementation does little to reduce fractures in schoolchildren with vitamin D deficiency

Among schoolchildren with a high baseline prevalence of vitamin D deficiency, oral supplementation with vitamin D for 3 years is safe but falls short of reducing the risk of fracture, according to a study.

Weight loss with tirzepatide reversed after stopping treatment

For individuals with overweight or obesity who are taking tirzepatide for weight management, continued treatment results in sustained and even augmented weight loss. When treatment is stopped, however, the achieved weight loss is substantially reversed.

Breakthrough SARS-CoV-2 infection does not affect blood sugar control in T1D patients

Patients with type 1 diabetes (T1D) who have been vaccinated against COVID-19 do not appear to have worsened glycaemic control, according to a study.

Teplizumab preserves ß-cell function in children with new-onset T1D

Treatment with teplizumab significantly preserved beta(ß)-cell function, as measured by C-peptide levels, in children and adolescents with new-onset type 1 diabetes (T1D) compared with placebo, according to the PROTECT* study.

Gliclazide Diabetes Mellitus D